"b cell receptor" trang 3 - tải miễn phí từ tailieunhanh
Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
8    72    0
Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature

Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature
6    87    0
Generalized crystal-storing histiocytosis with diffuse large B-cell lymphoma and monoclonal gammopathy in a Chinese elderly woman: A case report

Generalized crystal-storing histiocytosis with diffuse large B-cell lymphoma and monoclonal gammopathy in a Chinese elderly woman: A case report
8    98    0
Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count
10    97    0
An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
8    91    1
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
7    61    1
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
7    49    1
Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma
9    42    1
Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation

Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation
13    97    1
Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts diseasefree and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression

Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts diseasefree and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression
11    53    1
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: A meta-analysis

The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: A meta-analysis
13    33    1
Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience
8    30    1
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients

The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients
8    41    1
Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
12    68    1
Prophylactic antibiotic treatment with TMPSMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy

Prophylactic antibiotic treatment with TMPSMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy
7    52    1
Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement

Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement
7    33    1
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: A prospective, multicentre, non-interventional study

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: A prospective, multicentre, non-interventional study
10    77    1
Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma
7    64    1
Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia
8    57    1
MYC and BCL2 overexpression is associated with a higher class of Memorial SloanKettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system

MYC and BCL2 overexpression is associated with a higher class of Memorial SloanKettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system
11    93    1